{"gene":"COXFA4L3","run_date":"2026-06-09T22:57:19","timeline":{"discoveries":[{"year":2021,"finding":"C15ORF48 protein substitutes for the CcO subunit NDUFA4 in cytochrome c oxidase (Complex IV) during inflammation in primary macrophages, acting as a molecular switch that remodels CcO composition in response to inflammatory signals.","method":"Protein expression analysis, co-expression studies in primary macrophages, functional characterization with loss-of-function of NDUFA4 in inflammatory context","journal":"Science advances","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — primary macrophage studies with functional readouts, single lab but multiple lines of evidence including disease correlation and mechanistic characterization","pmids":["34878835"],"is_preprint":false},{"year":2020,"finding":"COXFA4L3 (C15ORF48/NMES1) is a novel accessory subunit of mitochondrial electron transport chain Complex IV (cytochrome c oxidase), representing the third isoform of COXFA4, and shows mutually exclusive expression with COXFA4 during spermatogenesis, replacing COXFA4 in Complex IV before meiosis.","method":"Amino acid sequence comparison, intracellular localization studies, protein expression profiling during spermatogenesis","journal":"Mitochondrion","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct localization and expression data in spermatogenic cells, single lab, multiple orthogonal methods (sequence, localization, expression)","pmids":["32045714"],"is_preprint":false},{"year":2024,"finding":"C15ORF48 reduces mitochondrial membrane potential and lowers intracellular ATP levels, thereby activating AMPK and its downstream target ULK1, inducing stress-independent autophagy; this autophagy upregulates intracellular glutathione levels, reducing oxidative stress and promoting cell survival. C15orf48-knockout mice show reduced stress-independent autophagy in thymic epithelial cells and develop autoimmunity.","method":"C15orf48 knockout mouse model, mitochondrial membrane potential measurement, ATP level measurement, AMPK/ULK1 pathway analysis, glutathione measurement, autophagy assays in thymic epithelial cells","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (KO mice, biochemical pathway dissection, metabolite measurement) establishing a defined mechanistic pathway with in vivo validation","pmids":["38296961"],"is_preprint":false},{"year":2024,"finding":"C15ORF48 protein displaces NDUFA4 from Complex IV (CIV) and promotes its subsequent degradation; this displacement requires a unique C-terminal α-helical domain of C15ORF48. NDUFA4 silencing by C15ORF48 and co-encoded miR-147-3p hinders NF-κB signaling activation and attenuates inflammatory responses in intestinal epithelium. Ablation of C15ORF48/miR-147 leads to gut dysbiosis and exacerbates colitis in mice.","method":"Domain mutagenesis (C-terminal α-helical domain), protein complex analysis, NF-κB signaling assays, mouse knockout model with chemically induced colitis, NDUFA4 protein level measurements","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — mutagenesis identifying functional domain, mechanistic pathway dissection (NDUFA4 displacement/degradation → NF-κB suppression), in vivo validation with KO mice","pmids":["38917002"],"is_preprint":false},{"year":2023,"finding":"NMES1 (C15ORF48) influences macrophage response to the tissue remodeling cytokine IL-4 in vitro, and its ablation in mice results in decreased intestinal regeneration during colitis recovery phase and altered CX3CR1+ macrophage responses.","method":"In vitro IL-4 stimulation of macrophages from Nmes1-ablated mice, two murine models of intestinal damage (colitis recovery and Schistosoma mansoni infection), CX3CR1+ macrophage analysis","journal":"European journal of immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — KO mouse model with defined cellular phenotype (macrophage response, tissue regeneration), single lab, two orthogonal in vivo models","pmids":["37971166"],"is_preprint":false},{"year":2026,"finding":"COXFA4L3 (C15ORF48) confers resistance to DNA-damaging anticancer agents by inhibiting cytosolic release of TFAM-unbound mitochondrial DNA via repression of mtDNA damage and mitochondrial permeability transition pore (mPTP) opening, thereby suppressing cGAS-STING innate immune signaling activation and preventing cell death.","method":"COXFA4L3 gain/loss-of-function experiments, mtDNA damage assays, mPTP opening measurement, cytosolic mtDNA detection, cGAS-STING pathway activation assays, cell death assays","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — mechanistic pathway dissection with multiple readouts (mtDNA damage, mPTP, cGAS-STING), single lab, single publication","pmids":["42243168"],"is_preprint":false},{"year":2026,"finding":"C15ORF48 knockdown in breast cancer basal cells increases reactive oxygen species (ROS) accumulation and apoptosis in response to doxorubicin/cyclophosphamide treatment, demonstrating that C15ORF48 blunts ROS accumulation and confers chemotherapy resistance; basal cells show reciprocal up-regulation of C15ORF48 and down-regulation of NDUFA4.","method":"Single-cell RNA sequencing of patient-derived xenografts, C15ORF48 knockdown in breast cancer cell lines, ROS measurement, apoptosis assays, drug sensitivity assays","journal":"Science advances","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional knockdown with defined molecular phenotype (ROS, apoptosis), single lab, orthogonal methods (scRNA-seq plus cellular assays)","pmids":["41931605"],"is_preprint":false},{"year":2025,"finding":"C15orf48 knockdown in NSCLC cells (A549, H1299) reduces proliferation, invasion, and adhesion while increasing apoptosis, and is associated with decreased expression of NF-κB pathway proteins (PLAUR, IKBα, IL-1RN, ICAM1, TMPRSS4); tumor growth was also inhibited in vivo in a xenograft model.","method":"shRNA knockdown, CCK8, colony formation, wound healing, transwell migration, flow cytometry, cell adhesion assays, xenograft tumor model, Western blotting for NF-κB pathway proteins","journal":"Biomolecules & biomedicine","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — loss-of-function with multiple cellular phenotype readouts and in vivo validation, NF-κB pathway placement by Western blot, single lab","pmids":["39576886"],"is_preprint":false},{"year":2002,"finding":"NMES1 (C15ORF48) protein is localized to the nucleus in esophageal epithelial cells, as determined by immunohistochemistry.","method":"Immunohistochemistry on esophageal tissue sections","journal":"International journal of cancer","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single method (IHC), single lab, no functional consequence linked to nuclear localization; note this conflicts with later evidence of mitochondrial localization","pmids":["12209954"],"is_preprint":false}],"current_model":"COXFA4L3 (C15ORF48/NMES1) is a mitochondrial accessory subunit of cytochrome c oxidase (Complex IV) that acts as a paralog of NDUFA4; upon inflammatory or stress signals, it displaces and promotes degradation of NDUFA4 from Complex IV via its unique C-terminal α-helical domain, thereby suppressing NF-κB signaling and modulating mitochondrial respiration, ROS production, membrane potential, and ATP levels — which in turn activates AMPK-ULK1-dependent autophagy, upregulates glutathione to reduce oxidative stress, and influences self-tolerance, gut homeostasis, and resistance to chemotherapy."},"narrative":{"mechanistic_narrative":"COXFA4L3 (C15ORF48/NMES1) is a mitochondrial accessory subunit of cytochrome c oxidase (Complex IV) that functions as a stress- and inflammation-responsive paralog of the canonical Complex IV subunit, remodeling enzyme composition in response to physiological cues [PMID:34878835, PMID:32045714]. It is incorporated into Complex IV in place of NDUFA4, displacing NDUFA4 and promoting its degradation through a unique C-terminal α-helical domain; together with its co-encoded miR-147-3p, this suppresses NF-κB signaling and attenuates inflammatory responses in intestinal epithelium, and its ablation produces gut dysbiosis and exacerbated colitis in mice [PMID:38917002]. This subunit substitution reshapes mitochondrial bioenergetics: COXFA4L3 lowers mitochondrial membrane potential and ATP, activating an AMPK–ULK1 axis that drives stress-independent autophagy and upregulates glutathione to limit oxidative stress, a circuit required in thymic epithelial cells for self-tolerance such that knockout mice develop autoimmunity [PMID:38296961]. In cancer, COXFA4L3 blunts ROS accumulation and confers resistance to DNA-damaging chemotherapy, in part by repressing mtDNA damage and mitochondrial permeability transition pore opening to prevent cytosolic mtDNA release and cGAS-STING activation [PMID:42243168, PMID:41931605]. An early report of nuclear localization in esophageal epithelium [PMID:12209954] conflicts with the consistent mitochondrial localization established by later work.","teleology":[{"year":2020,"claim":"Established COXFA4L3 as a distinct accessory subunit of Complex IV, defining it as a tissue-specific isoform that can substitute for the canonical subunit rather than an unrelated protein.","evidence":"Sequence comparison, intracellular localization, and expression profiling during spermatogenesis","pmids":["32045714"],"confidence":"Medium","gaps":["Did not establish the structural basis or functional consequence of subunit substitution","Restricted to spermatogenic context"]},{"year":2021,"claim":"Showed that subunit substitution is an inducible inflammatory switch, linking COXFA4L3 to Complex IV remodeling in immune cells.","evidence":"Protein expression and co-expression studies with NDUFA4 loss-of-function in primary macrophages","pmids":["34878835"],"confidence":"Medium","gaps":["Did not define the molecular determinant of NDUFA4 displacement","Bioenergetic consequences not quantified"]},{"year":2023,"claim":"Connected COXFA4L3 to macrophage cytokine responses and tissue regeneration, broadening its role from a metabolic subunit to a modulator of intestinal repair.","evidence":"Nmes1-ablated mice, IL-4 stimulation in vitro, two intestinal damage models, CX3CR1+ macrophage analysis","pmids":["37971166"],"confidence":"Medium","gaps":["Mechanistic link between subunit function and macrophage phenotype not resolved","Did not separate metabolic from signaling contributions"]},{"year":2024,"claim":"Defined the bioenergetic-to-autophagy circuit, showing how COXFA4L3 lowers membrane potential and ATP to engage AMPK-ULK1 autophagy and glutathione-mediated cytoprotection, and tied this to self-tolerance.","evidence":"C15orf48 knockout mice, membrane potential/ATP/glutathione measurement, AMPK/ULK1 pathway analysis, autophagy assays in thymic epithelial cells","pmids":["38296961"],"confidence":"High","gaps":["Direct biochemical coupling between Complex IV remodeling and membrane potential drop not isolated","Generalizability beyond thymic epithelium untested"]},{"year":2024,"claim":"Identified the C-terminal α-helical domain as the determinant of NDUFA4 displacement/degradation and placed COXFA4L3 (with miR-147-3p) upstream of NF-κB suppression in gut homeostasis.","evidence":"Domain mutagenesis, complex analysis, NF-κB assays, NDUFA4 level measurement, colitis knockout model","pmids":["38917002"],"confidence":"High","gaps":["Relative contributions of protein vs. miR-147-3p to NF-κB suppression not fully separated","Mechanism linking NDUFA4 loss to NF-κB output not defined at molecular level"]},{"year":2025,"claim":"Positioned COXFA4L3 as a pro-tumorigenic NF-κB-associated factor in NSCLC, where its loss reduces proliferation/invasion and increases apoptosis.","evidence":"shRNA knockdown in A549/H1299, proliferation/migration/adhesion/apoptosis assays, xenograft model, NF-κB protein Western blots","pmids":["39576886"],"confidence":"Medium","gaps":["NF-κB pathway placement rests on Western blot association, not direct mechanism","Single cancer type and lab"]},{"year":2026,"claim":"Established COXFA4L3 as a mediator of chemotherapy resistance, blunting ROS accumulation and suppressing cytosolic mtDNA release and cGAS-STING signaling to prevent cell death.","evidence":"Gain/loss-of-function with mtDNA damage, mPTP, cytosolic mtDNA, cGAS-STING, ROS, and apoptosis assays; scRNA-seq of patient-derived xenografts","pmids":["42243168","41931605"],"confidence":"Medium","gaps":["Mechanism connecting Complex IV remodeling to mPTP/mtDNA protection not biochemically resolved","Single-lab findings per study"]},{"year":null,"claim":"How a single Complex IV subunit substitution mechanistically couples to the divergent downstream outputs (NF-κB suppression, AMPK-ULK1 autophagy, cGAS-STING dampening) and whether these arise from shared bioenergetic changes or independent activities remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No structural model of the COXFA4L3-containing Complex IV","Causal hierarchy among membrane potential, ROS, and signaling outputs undefined"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0005198","term_label":"structural molecule activity","supporting_discovery_ids":[0,1,3]}],"localization":[{"term_id":"GO:0005739","term_label":"mitochondrion","supporting_discovery_ids":[0,1,2]}],"pathway":[{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[0,1,2]},{"term_id":"R-HSA-9612973","term_label":"Autophagy","supporting_discovery_ids":[2]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[3,4,5]}],"complexes":["Cytochrome c oxidase (Complex IV)"],"partners":["NDUFA4"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q9C002","full_name":"Cytochrome c oxidase associated subunit FA4L3","aliases":["Modulator of cytochrome C oxidase during inflammation protein","MOCCI","Normal mucosa of esophagus-specific gene 1 protein","NMES1","Protein FOAP-11"],"length_aa":83,"mass_kda":9.6,"function":"Mitochondrial small peptide that orchestrates a two-pronged immunoregulatory mechanism in response to inflammatory stimuli. Replaces the canonical cytochrome c oxidase subunit COXFA4 in mitochondrial complex IV and targets it to degradation, attenuating mitochondrial respiration, reducing membrane potential as well as ROS generation and modulates innate immune signaling (PubMed:33837217, PubMed:34878835). Additionally, initiates stress-independent autophagy by lowering ATP levels, activating AMPK-ULK1 signaling, boosting glutathione production, and thereby mitigating oxidative stress and supporting immune tolerance (PubMed:38296961)","subcellular_location":"Mitochondrion inner membrane","url":"https://www.uniprot.org/uniprotkb/Q9C002/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"C15ORF48","url":"https://depmap.org/portal/gene/C15ORF48"},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/COXFA4L3","total_profiled":1310},"omim":[{"mim_id":"601661","title":"UBIQUITIN-CONJUGATING ENZYME E2 I; UBE2I","url":"https://www.omim.org/entry/601661"}],"hpa":{"profiled":true,"resolved_as":"C15ORF48","reliability":"","locations":[],"tissue_specificity":"Tissue enriched","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"intestine","ntpm":866.5}],"url":"https://www.proteinatlas.org/search/C15ORF48"},"hgnc":{"alias_symbol":["NMES1","MIR147BHG","COXFA4L3","MOCCI","MISTRAV"],"prev_symbol":["C15orf48"]},"alphafold":{"accession":"Q9C002","domains":[{"cath_id":"-","chopping":"48-83","consensus_level":"medium","plddt":89.7228,"start":48,"end":83},{"cath_id":"1.20.5","chopping":"1-36","consensus_level":"medium","plddt":92.7086,"start":1,"end":36}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9C002","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q9C002-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q9C002-F1-predicted_aligned_error_v6.png","plddt_mean":90.31},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=COXFA4L3","jax_strain_url":"https://www.jax.org/strain/search?query=COXFA4L3"},"sequence":{"accession":"Q9C002","fasta_url":"https://rest.uniprot.org/uniprotkb/Q9C002.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q9C002/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9C002"}},"corpus_meta":[{"pmid":"34878835","id":"PMC_34878835","title":"Inflammation causes remodeling of mitochondrial cytochrome c oxidase mediated by the bifunctional gene C15orf48.","date":"2021","source":"Science advances","url":"https://pubmed.ncbi.nlm.nih.gov/34878835","citation_count":49,"is_preprint":false},{"pmid":"12209954","id":"PMC_12209954","title":"A novel gene, NMES1, downregulated in human esophageal squamous cell carcinoma.","date":"2002","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/12209954","citation_count":38,"is_preprint":false},{"pmid":"38296961","id":"PMC_38296961","title":"Mitochondrial protein C15ORF48 is a stress-independent inducer of autophagy that regulates oxidative stress and autoimmunity.","date":"2024","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/38296961","citation_count":26,"is_preprint":false},{"pmid":"32045714","id":"PMC_32045714","title":"Coxfa4l3, a novel mitochondrial electron transport chain Complex 4 subunit protein, switches from Coxfa4 during spermatogenesis.","date":"2020","source":"Mitochondrion","url":"https://pubmed.ncbi.nlm.nih.gov/32045714","citation_count":20,"is_preprint":false},{"pmid":"38917002","id":"PMC_38917002","title":"The epithelial C15ORF48/miR-147-NDUFA4 axis is an essential regulator of gut inflammation, energy metabolism, and the microbiome.","date":"2024","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/38917002","citation_count":9,"is_preprint":false},{"pmid":"39478730","id":"PMC_39478730","title":"Ectopic expression of the mitochondrial protein COXFA4L3 in human sperm acrosome and its potential application in the selection of male infertility treatments.","date":"2024","source":"Reproductive medicine and biology","url":"https://pubmed.ncbi.nlm.nih.gov/39478730","citation_count":5,"is_preprint":false},{"pmid":"37971166","id":"PMC_37971166","title":"Nmes1 is a novel regulator of mucosal response influencing intestinal healing potential.","date":"2023","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/37971166","citation_count":2,"is_preprint":false},{"pmid":"40998903","id":"PMC_40998903","title":"C15ORF48 serves as a potential biomarker and therapeutic target in pan-cancer with implications for lung cancer.","date":"2025","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/40998903","citation_count":0,"is_preprint":false},{"pmid":"41931605","id":"PMC_41931605","title":"Regulation of mitochondrial ROS by C15ORF48 in a basal cell subpopulation contributes to chemotherapy resistance in TNBC.","date":"2026","source":"Science advances","url":"https://pubmed.ncbi.nlm.nih.gov/41931605","citation_count":0,"is_preprint":false},{"pmid":"42243168","id":"PMC_42243168","title":"Mitochondrial protein COXFA4L3 (C15ORF48) confers resistance to DNA-damaging anticancer agents by repressing mitochondrial DNA damage responses.","date":"2026","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/42243168","citation_count":0,"is_preprint":false},{"pmid":"39576886","id":"PMC_39576886","title":"Unveiling the impact of C15orf48 on non-small cell lung cancer through NF-kappa B signaling.","date":"2025","source":"Biomolecules & biomedicine","url":"https://pubmed.ncbi.nlm.nih.gov/39576886","citation_count":0,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":7075,"output_tokens":2406,"usd":0.028657,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":9604,"output_tokens":2709,"usd":0.057873,"stage2_stop_reason":"end_turn"},"total_usd":0.08653,"stage1_batch_id":"msgbatch_01ACAxJQabDsht39JXeWG22d","stage2_batch_id":"msgbatch_01QEU22A9U5sbPTgsMzTmvSf","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2021,\n      \"finding\": \"C15ORF48 protein substitutes for the CcO subunit NDUFA4 in cytochrome c oxidase (Complex IV) during inflammation in primary macrophages, acting as a molecular switch that remodels CcO composition in response to inflammatory signals.\",\n      \"method\": \"Protein expression analysis, co-expression studies in primary macrophages, functional characterization with loss-of-function of NDUFA4 in inflammatory context\",\n      \"journal\": \"Science advances\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — primary macrophage studies with functional readouts, single lab but multiple lines of evidence including disease correlation and mechanistic characterization\",\n      \"pmids\": [\"34878835\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"COXFA4L3 (C15ORF48/NMES1) is a novel accessory subunit of mitochondrial electron transport chain Complex IV (cytochrome c oxidase), representing the third isoform of COXFA4, and shows mutually exclusive expression with COXFA4 during spermatogenesis, replacing COXFA4 in Complex IV before meiosis.\",\n      \"method\": \"Amino acid sequence comparison, intracellular localization studies, protein expression profiling during spermatogenesis\",\n      \"journal\": \"Mitochondrion\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct localization and expression data in spermatogenic cells, single lab, multiple orthogonal methods (sequence, localization, expression)\",\n      \"pmids\": [\"32045714\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"C15ORF48 reduces mitochondrial membrane potential and lowers intracellular ATP levels, thereby activating AMPK and its downstream target ULK1, inducing stress-independent autophagy; this autophagy upregulates intracellular glutathione levels, reducing oxidative stress and promoting cell survival. C15orf48-knockout mice show reduced stress-independent autophagy in thymic epithelial cells and develop autoimmunity.\",\n      \"method\": \"C15orf48 knockout mouse model, mitochondrial membrane potential measurement, ATP level measurement, AMPK/ULK1 pathway analysis, glutathione measurement, autophagy assays in thymic epithelial cells\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (KO mice, biochemical pathway dissection, metabolite measurement) establishing a defined mechanistic pathway with in vivo validation\",\n      \"pmids\": [\"38296961\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"C15ORF48 protein displaces NDUFA4 from Complex IV (CIV) and promotes its subsequent degradation; this displacement requires a unique C-terminal α-helical domain of C15ORF48. NDUFA4 silencing by C15ORF48 and co-encoded miR-147-3p hinders NF-κB signaling activation and attenuates inflammatory responses in intestinal epithelium. Ablation of C15ORF48/miR-147 leads to gut dysbiosis and exacerbates colitis in mice.\",\n      \"method\": \"Domain mutagenesis (C-terminal α-helical domain), protein complex analysis, NF-κB signaling assays, mouse knockout model with chemically induced colitis, NDUFA4 protein level measurements\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — mutagenesis identifying functional domain, mechanistic pathway dissection (NDUFA4 displacement/degradation → NF-κB suppression), in vivo validation with KO mice\",\n      \"pmids\": [\"38917002\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"NMES1 (C15ORF48) influences macrophage response to the tissue remodeling cytokine IL-4 in vitro, and its ablation in mice results in decreased intestinal regeneration during colitis recovery phase and altered CX3CR1+ macrophage responses.\",\n      \"method\": \"In vitro IL-4 stimulation of macrophages from Nmes1-ablated mice, two murine models of intestinal damage (colitis recovery and Schistosoma mansoni infection), CX3CR1+ macrophage analysis\",\n      \"journal\": \"European journal of immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — KO mouse model with defined cellular phenotype (macrophage response, tissue regeneration), single lab, two orthogonal in vivo models\",\n      \"pmids\": [\"37971166\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"COXFA4L3 (C15ORF48) confers resistance to DNA-damaging anticancer agents by inhibiting cytosolic release of TFAM-unbound mitochondrial DNA via repression of mtDNA damage and mitochondrial permeability transition pore (mPTP) opening, thereby suppressing cGAS-STING innate immune signaling activation and preventing cell death.\",\n      \"method\": \"COXFA4L3 gain/loss-of-function experiments, mtDNA damage assays, mPTP opening measurement, cytosolic mtDNA detection, cGAS-STING pathway activation assays, cell death assays\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — mechanistic pathway dissection with multiple readouts (mtDNA damage, mPTP, cGAS-STING), single lab, single publication\",\n      \"pmids\": [\"42243168\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"C15ORF48 knockdown in breast cancer basal cells increases reactive oxygen species (ROS) accumulation and apoptosis in response to doxorubicin/cyclophosphamide treatment, demonstrating that C15ORF48 blunts ROS accumulation and confers chemotherapy resistance; basal cells show reciprocal up-regulation of C15ORF48 and down-regulation of NDUFA4.\",\n      \"method\": \"Single-cell RNA sequencing of patient-derived xenografts, C15ORF48 knockdown in breast cancer cell lines, ROS measurement, apoptosis assays, drug sensitivity assays\",\n      \"journal\": \"Science advances\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional knockdown with defined molecular phenotype (ROS, apoptosis), single lab, orthogonal methods (scRNA-seq plus cellular assays)\",\n      \"pmids\": [\"41931605\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"C15orf48 knockdown in NSCLC cells (A549, H1299) reduces proliferation, invasion, and adhesion while increasing apoptosis, and is associated with decreased expression of NF-κB pathway proteins (PLAUR, IKBα, IL-1RN, ICAM1, TMPRSS4); tumor growth was also inhibited in vivo in a xenograft model.\",\n      \"method\": \"shRNA knockdown, CCK8, colony formation, wound healing, transwell migration, flow cytometry, cell adhesion assays, xenograft tumor model, Western blotting for NF-κB pathway proteins\",\n      \"journal\": \"Biomolecules & biomedicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — loss-of-function with multiple cellular phenotype readouts and in vivo validation, NF-κB pathway placement by Western blot, single lab\",\n      \"pmids\": [\"39576886\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"NMES1 (C15ORF48) protein is localized to the nucleus in esophageal epithelial cells, as determined by immunohistochemistry.\",\n      \"method\": \"Immunohistochemistry on esophageal tissue sections\",\n      \"journal\": \"International journal of cancer\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single method (IHC), single lab, no functional consequence linked to nuclear localization; note this conflicts with later evidence of mitochondrial localization\",\n      \"pmids\": [\"12209954\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"COXFA4L3 (C15ORF48/NMES1) is a mitochondrial accessory subunit of cytochrome c oxidase (Complex IV) that acts as a paralog of NDUFA4; upon inflammatory or stress signals, it displaces and promotes degradation of NDUFA4 from Complex IV via its unique C-terminal α-helical domain, thereby suppressing NF-κB signaling and modulating mitochondrial respiration, ROS production, membrane potential, and ATP levels — which in turn activates AMPK-ULK1-dependent autophagy, upregulates glutathione to reduce oxidative stress, and influences self-tolerance, gut homeostasis, and resistance to chemotherapy.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"COXFA4L3 (C15ORF48/NMES1) is a mitochondrial accessory subunit of cytochrome c oxidase (Complex IV) that functions as a stress- and inflammation-responsive paralog of the canonical Complex IV subunit, remodeling enzyme composition in response to physiological cues [#0, #1]. It is incorporated into Complex IV in place of NDUFA4, displacing NDUFA4 and promoting its degradation through a unique C-terminal α-helical domain; together with its co-encoded miR-147-3p, this suppresses NF-κB signaling and attenuates inflammatory responses in intestinal epithelium, and its ablation produces gut dysbiosis and exacerbated colitis in mice [#3]. This subunit substitution reshapes mitochondrial bioenergetics: COXFA4L3 lowers mitochondrial membrane potential and ATP, activating an AMPK–ULK1 axis that drives stress-independent autophagy and upregulates glutathione to limit oxidative stress, a circuit required in thymic epithelial cells for self-tolerance such that knockout mice develop autoimmunity [#2]. In cancer, COXFA4L3 blunts ROS accumulation and confers resistance to DNA-damaging chemotherapy, in part by repressing mtDNA damage and mitochondrial permeability transition pore opening to prevent cytosolic mtDNA release and cGAS-STING activation [#5, #6]. An early report of nuclear localization in esophageal epithelium [#8] conflicts with the consistent mitochondrial localization established by later work.\",\n  \"teleology\": [\n    {\n      \"year\": 2020,\n      \"claim\": \"Established COXFA4L3 as a distinct accessory subunit of Complex IV, defining it as a tissue-specific isoform that can substitute for the canonical subunit rather than an unrelated protein.\",\n      \"evidence\": \"Sequence comparison, intracellular localization, and expression profiling during spermatogenesis\",\n      \"pmids\": [\"32045714\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Did not establish the structural basis or functional consequence of subunit substitution\", \"Restricted to spermatogenic context\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Showed that subunit substitution is an inducible inflammatory switch, linking COXFA4L3 to Complex IV remodeling in immune cells.\",\n      \"evidence\": \"Protein expression and co-expression studies with NDUFA4 loss-of-function in primary macrophages\",\n      \"pmids\": [\"34878835\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Did not define the molecular determinant of NDUFA4 displacement\", \"Bioenergetic consequences not quantified\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Connected COXFA4L3 to macrophage cytokine responses and tissue regeneration, broadening its role from a metabolic subunit to a modulator of intestinal repair.\",\n      \"evidence\": \"Nmes1-ablated mice, IL-4 stimulation in vitro, two intestinal damage models, CX3CR1+ macrophage analysis\",\n      \"pmids\": [\"37971166\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanistic link between subunit function and macrophage phenotype not resolved\", \"Did not separate metabolic from signaling contributions\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Defined the bioenergetic-to-autophagy circuit, showing how COXFA4L3 lowers membrane potential and ATP to engage AMPK-ULK1 autophagy and glutathione-mediated cytoprotection, and tied this to self-tolerance.\",\n      \"evidence\": \"C15orf48 knockout mice, membrane potential/ATP/glutathione measurement, AMPK/ULK1 pathway analysis, autophagy assays in thymic epithelial cells\",\n      \"pmids\": [\"38296961\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct biochemical coupling between Complex IV remodeling and membrane potential drop not isolated\", \"Generalizability beyond thymic epithelium untested\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Identified the C-terminal α-helical domain as the determinant of NDUFA4 displacement/degradation and placed COXFA4L3 (with miR-147-3p) upstream of NF-κB suppression in gut homeostasis.\",\n      \"evidence\": \"Domain mutagenesis, complex analysis, NF-κB assays, NDUFA4 level measurement, colitis knockout model\",\n      \"pmids\": [\"38917002\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Relative contributions of protein vs. miR-147-3p to NF-κB suppression not fully separated\", \"Mechanism linking NDUFA4 loss to NF-κB output not defined at molecular level\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Positioned COXFA4L3 as a pro-tumorigenic NF-κB-associated factor in NSCLC, where its loss reduces proliferation/invasion and increases apoptosis.\",\n      \"evidence\": \"shRNA knockdown in A549/H1299, proliferation/migration/adhesion/apoptosis assays, xenograft model, NF-κB protein Western blots\",\n      \"pmids\": [\"39576886\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"NF-κB pathway placement rests on Western blot association, not direct mechanism\", \"Single cancer type and lab\"]\n    },\n    {\n      \"year\": 2026,\n      \"claim\": \"Established COXFA4L3 as a mediator of chemotherapy resistance, blunting ROS accumulation and suppressing cytosolic mtDNA release and cGAS-STING signaling to prevent cell death.\",\n      \"evidence\": \"Gain/loss-of-function with mtDNA damage, mPTP, cytosolic mtDNA, cGAS-STING, ROS, and apoptosis assays; scRNA-seq of patient-derived xenografts\",\n      \"pmids\": [\"42243168\", \"41931605\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism connecting Complex IV remodeling to mPTP/mtDNA protection not biochemically resolved\", \"Single-lab findings per study\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How a single Complex IV subunit substitution mechanistically couples to the divergent downstream outputs (NF-κB suppression, AMPK-ULK1 autophagy, cGAS-STING dampening) and whether these arise from shared bioenergetic changes or independent activities remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No structural model of the COXFA4L3-containing Complex IV\", \"Causal hierarchy among membrane potential, ROS, and signaling outputs undefined\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0005198\", \"supporting_discovery_ids\": [0, 1, 3]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005739\", \"supporting_discovery_ids\": [0, 1, 2]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [0, 1, 2]},\n      {\"term_id\": \"R-HSA-9612973\", \"supporting_discovery_ids\": [2]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [3, 4, 5]}\n    ],\n    \"complexes\": [\"Cytochrome c oxidase (Complex IV)\"],\n    \"partners\": [\"NDUFA4\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":4,"faith_total":5,"faith_pct":80.0}}